Adjuvant versus neoadjuvant androgen deprivation with radiation therapy for prostate cancer: Does sequencing matter?

Authors

null

Michael A. Weller

Cleveland Clinic, Cleveland, OH

Michael A. Weller , Rahul D. Tendulkar , Chandana A. Reddy , Kevin L. Stephans , Patrick Kupelian

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 37)

DOI

10.1200/jco.2013.31.6_suppl.37

Abstract #

37

Poster Bd #

C10

Abstract Disclosures

Similar Posters

Poster

2016 ASCO Annual Meeting

<em>HSD3B1</em> and resistance to androgen deprivation therapy in prostate cancer.

HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.

First Author: Jason W.D. Hearn

Poster

2015 ASCO Annual Meeting

<em>HSD3B1</em> and resistance to androgen deprivation therapy in prostate cancer.

HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.

First Author: Jason W.D. Hearn

Poster

2015 Genitourinary Cancers Symposium

<em>HSD3B1</em> and resistance to androgen deprivation therapy in prostate cancer.

HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.

First Author: Jason W.D. Hearn

First Author: Soumyajit Roy